Edward is a former academic hematologist-oncologist who has served as Chief Medical Officer for leading private and public biopharmaceutical companies during his 15 years in the industry. Prior to a transition into consulting in 2015, Dr. Garmey served as Chief Medical Officer and Senior Vice President at Cerulean Pharma where he oversaw the initiation of several multi-national clinical trials across multiple drug programs and helped lead the company’s successful $67 MM IPO. Earlier in his career, Dr. Garmey served as a pediatric hematologist-oncologist at Memorial Sloan-Kettering Cancer Center.

He is an alumnus of Harvard and New York Universities and completed his medical training at the Children’s Hospital of Los Angeles and MSKCC. Dr. Garmey completed additional research fellowships at the National Institutes of Health and the Botswana-Harvard Partnership for H.I.V. Research and is recipient of the young investigators awards from the American Society of Hematology and the American Heart Association.

Dr. Garmey resides in the Boston area where he serves as an adjunct instructor at Harvard Medical School’s Graduate Program in Therapeutic Science and serves as a member of the Board of Overseers at the Beth Israel Deaconess Medical Center.